GENNEX LABORATORIES LTD. Share Price

Gennex Laboratories Limited is an India-based active pharmaceutical ingredient manufacturing company. The Company is engaged in the business of manufacturing of bulk drugs and intermediaries. It offers products in various therapeutic categories, including expectorant (mucolyte), relaxant (skeletal muscle relaxant), antihistamines, urinary tract analgesic, antifungals called triazoles, tricyclic antidepressant, acting muscle relaxants, muscle relaxant, selective serotonin reuptake inhibitors (SSRIS), and xanthine oxidase inhibitors. Its products include Guaifenesin, Methocarbamol, Fexofenadine Hcl, Phenazopyridine Hcl, Fluconazole, Melitracen Hcl, Mephenesin, Chlorphenesin, Sertraline Hcl and Allopurinol. The Company has manufacturing facilities in India which cater to both domestic and international markets. Its international markets include Bangladesh, Bolivia, China, Colombia, Costa Rica, Cuba, Germany, Indonesia, Iran, Iraq, Israel, Jordan, Kenya, South Korea, Malaysia and Mexico.As of 25 May 2026, GENNEX LABORATORIES LTD. share price is ₹12.67. The stock opened at ₹12.68, compared to its previous close of ₹12.27. During today's trading session, GENNEX LABORATORIES LTD. share price moved in the range of ₹12.11 to ₹12.99, with an average price of ₹12.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹12.11 and a high of ₹12.99.

The market capitalization of GENNEX LABORATORIES LTD. is ₹298 Crs, with a P/E ratio of 15.2 and a dividend yield of 0.00%.